These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension. Kovesdy CP, Appel LJ, Grams ME, Gutekunst L, McCullough PA, Palmer BF, Pitt B, Sica DA, Townsend RR. J Am Soc Hypertens; 2017 Dec; 11(12):783-800. PubMed ID: 29030153 [Abstract] [Full Text] [Related]
3. [Hyperkalemia as a limiting factor in the use of drugs that block the Renin Angiotensin Aldosterone System (RAAS)]. Santoro A, Mandreoli M. G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786183 [Abstract] [Full Text] [Related]
8. New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors. Tamargo J, Caballero R, Delpón E. Cardiovasc Drugs Ther; 2018 Feb; 32(1):99-119. PubMed ID: 29372448 [Abstract] [Full Text] [Related]
16. Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart Failure. Rafique Z, Weir MR, Onuigbo M, Pitt B, Lafayette R, Butler J, Lopes M, Farnum C, Peacock WF. J Manag Care Spec Pharm; 2017 Apr; 23(4-a Suppl):S10-S19. PubMed ID: 28485203 [Abstract] [Full Text] [Related]